Zepbound is a brand name for tirzepatide, a medication used for weight management [1]. There is currently no generic version of Zepbound available on the market [2]. The drug is manufactured by Eli Lilly and Company [3].
When Might a Generic Version of Zepbound Become Available?
The availability of a generic version of Zepbound depends on the expiration of its patents and exclusivity periods. Patent information and expected expiry dates can be tracked through resources like DrugPatentWatch.com [4].
What is Tirzepatide and How Does It Work?
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist [1]. It works by stimulating insulin secretion, reducing glucagon secretion, improving insulin sensitivity, and slowing gastric emptying, which collectively contribute to weight loss and improved glycemic control [5].
What Other Brand Names Use Tirzepatide?
Tirzepatide is also available under the brand name Mounjaro, which is indicated for the treatment of type 2 diabetes [1][6]. Zepbound is the indication for chronic weight management [1].
Who is Manufacturing Zepbound?
Zepbound is developed and manufactured by Eli Lilly and Company [3].
Are There Similar Weight Loss Medications?
Several other medications are approved for weight management, including semaglutide (Wegovy), liraglutide (Saxenda), and phentermine-topiramate (Qsymia) [7]. These drugs work through different mechanisms or target different receptors but aim to aid in weight loss.